OGN
Organon & Co.
$10.45
-$0.40(-3.69%)
55
Overall
95
Value
36
Tech
34
Quality
Market Cap
$2.72B
Volume
9.66M
52W Range
$8.01 - $19.83
Target Price
$13.17
Order:
Income Statement
| Metric | Trend | Chart | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|
| REVENUE | ||||||
| Total Revenue | $6.3B | $6.2B | $6.3B | $6.4B | ||
| Total Revenue | $6.3B | $6.2B | $6.3B | $6.4B | ||
| COST OF GOODS SOLD | ||||||
| Cost of Revenue | $2.4B | $2.3B | $2.5B | $2.7B | ||
| GROSS PROFIT | ||||||
| Gross Profit | $3.9B | $3.9B | $3.7B | $3.7B | ||
| OPERATING EXPENSES | ||||||
| Operating Expenses | $2.1B | $2.2B | $2.4B | $2.3B | ||
| Research & Development | $443.0M | $471.0M | $528.0M | $469.0M | ||
| Research Expense | $443.0M | $471.0M | $528.0M | $469.0M | ||
| Selling, General & Administrative | $1.7B | $1.7B | $1.9B | $1.8B | ||
| Selling & Marketing Expenses | $236.0M | $255.0M | $209.0M | $206.0M | ||
| General & Administrative Expenses | $1.7B | $1.7B | $1.9B | $1.8B | ||
| Promotion & Advertising | $236.0M | -- | -- | $81.0M | ||
| Salaries & Wages | $-12.0M | -- | -- | -- | ||
| Depreciation & Amortization | $92.0M | $96.0M | $120.0M | $132.0M | ||
| Depreciation & Amortization | $92.0M | -- | -- | -- | ||
| Amortization | $105.0M | $116.0M | $4.6B | $4.7B | ||
| Other Operating Expenses | $-23.0M | -- | -- | -- | ||
| OPERATING INCOME | ||||||
| Operating income | $1.8B | $1.7B | $1.3B | $1.4B | ||
| EBITDA | $2.0B | $1.8B | $1.4B | $1.6B | ||
| NON-OPERATING ITEMS | ||||||
| Interest Expense (Non-Operating) | $258.0M | $422.0M | $527.0M | $520.0M | ||
| Net Non-Operating Interest Income/Expense | $-258.0M | $-422.0M | $-527.0M | $-520.0M | ||
| Gain on Sale of Securities | $-56.0M | -- | -- | -- | ||
| Other Income/Expense | $56.0M | $-161.0M | $-127.0M | $2.0M | ||
| SPECIAL ITEMS | ||||||
| Restructring And Mn A Income | $3.0M | $28.0M | $62.0M | $31.0M | ||
| Special Income Charges | $-3.0M | $-28.0M | $-70.0M | $-31.0M | ||
| Impairment of Capital Assets | $7.0M | -- | -- | -- | ||
| PRE-TAX INCOME | ||||||
| EBIT | $1.8B | $1.5B | $1.2B | $1.3B | ||
| Pre-Tax Income | $1.5B | $1.1B | $673.0M | $807.0M | ||
| INCOME TAX | ||||||
| Tax Provision | $178.0M | $205.0M | $-350.0M | $-57.0M | ||
| NET INCOME | ||||||
| Net Income | $1.4B | $917.0M | $1.0B | $864.0M | ||
| Net Income (Continuing Operations) | $1.4B | $917.0M | $1.0B | $864.0M | ||
| Net Income (Discontinued Operations) | $1.4B | $917.0M | $1.0B | $864.0M | ||
| Net Income (Common Stockholders) | $1.4B | $917.0M | $1.0B | $864.0M | ||
| TOTALS | ||||||
| Total Expenses | $4.5B | $4.5B | $4.9B | $5.0B | ||
| SHARE & EPS DATA | ||||||
| Average Shares Outstanding | $253.5M | $254.1M | $255.2M | $257.0M | ||
| Average Shares Outstanding (Diluted) | $254.2M | $255.2M | $256.3M | $259.2M | ||
| Shares Outstanding | $253.6M | $254.4M | $255.6M | $515.9M | ||
| Basic EPS | $5.33 | $3.61 | $4.01 | $3.36 | ||
| Basic EPS (Continuing Operations) | $5.33 | $3.61 | $4.01 | $3.36 | ||
| Diluted EPS | $5.31 | $3.59 | $3.99 | $3.33 | ||
| Diluted EPS (Continuing Operations) | $5.31 | $3.59 | $3.99 | $3.33 | ||
| Dividend Per Share | -- | $1.12 | $1.12 | $1.12 | ||
| OTHER METRICS | ||||||
| Non Recurring Operation Expense | -- | -- | $8.0M | -- | ||
| Other Gand A | $1.7B | $1.7B | $1.9B | $1.8B | ||
| Other Write Down | -- | $107.0M | -- | -- | ||
| Selling Expense | -- | -- | $8.0M | -- | ||
| Restruct | $3.0M | $28.0M | $62.0M | $31.0M | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | OGN | $10.45 | -3.7% | 9.66M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |